banner
β-Catenin inhibitor FH535, Purity ≥98%
Inquiry

Cat. No.: X24-07-ZQ208

β-Catenin inhibitor FH535, Purity ≥98%

Synonym: 108409-83-2; β-Catenin inhibitor; FH-535; FH 535

  • MDL: MFCD01212888
  • CAS Number: 108409-83-2
  • Compound CID: 3463933
img
Product Size
25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
FH535, soluble in warmed DMSO and insoluble in water and ethanol, disrupts the Wnt/β-catenin signaling pathway, a critical pathway in regulating cell fate, proliferation, and stem cell renewal, providing significant therapeutic prospects in cancer and fibrotic diseases by curbing abnormal cell growth and differentiation. It targets PPARδ, PPARγ, and Wnt/β-catenin.
Molecular Weight
361.2
Molecular Formula
C13H10Cl2N2O4S
Targets
PPARδ; PPARγ; Wnt/β-catenin
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 61 mg/mL (168.88 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
FH535 is a β-Catenin inhibitor used to investigate the regulation of the Wnt/β-catenin signaling pathway in cancer.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0